Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Hims & Hers Health, Inc.HIMS · Entity 1878 | Chief Financial Officer | October 01, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Hims & Hers Health, Inc.
Report date October 01, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 234,527 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Sale · Disposed 2,000 · Balance 234,527 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 14, 2025 Filed Mar 18, 2025 22:35 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Tax withholdingClass A Common Stock | 51,671 | $33.14 | $1,712,376.94 |
DisclosureSEC source: 0001773751-25-000100 · wk-form4_1742337309.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,366 F2 · shares: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 22:35 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 93,718 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-25-000100 · wk-form4_1742337309.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,037 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| March 05, 2025 Filed Mar 6, 2025 21:32 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 2,530 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001773751-25-000081 · wk-form4_1741296715.xml · derivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 410,770 Underlying: Class A Common Stock · 2,530 shares Expires 2032-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date. Read SEC document |
| March 05, 2025 Filed Mar 6, 2025 21:32 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 2,530 | $5.01 | $12,675.30 |
DisclosureSEC source: 0001773751-25-000081 · wk-form4_1741296715.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,319 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:42 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 183,719 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-25-000076 · wk-form4_1741210940.xml · derivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,719 Underlying: Class A Common Stock · 183,719 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2025. F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2025. Read SEC document |
| February 10, 2025 Filed Feb 11, 2025 21:16 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 6,437 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001773751-25-000039 · wk-form4_1739308580.xml · derivative · entry 5 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 413,300 Underlying: Class A Common Stock · 6,437 shares Expires 2032-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F5 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date. Read SEC document |
| February 10, 2025 Filed Feb 11, 2025 21:16 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 997 | $43.23 | $43,103.70 |
DisclosureSEC source: 0001773751-25-000039 · wk-form4_1739308580.xml · nonDerivative · entry 4 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 107,789 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $43.18 - $43.345. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| February 10, 2025 Filed Feb 11, 2025 21:16 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 1,391 | $43.21 | $60,098.57 |
DisclosureSEC source: 0001773751-25-000039 · wk-form4_1739308580.xml · nonDerivative · entry 3 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,786 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $43.12 - $43.345. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| February 10, 2025 Filed Feb 11, 2025 21:16 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 9,193 | $42.96 | $394,898.19 |
DisclosureSEC source: 0001773751-25-000039 · wk-form4_1739308580.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 110,177 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $42.59 - $43.345. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| February 10, 2025 Filed Feb 11, 2025 21:16 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 6,437 | $5.01 | $32,249.37 |
DisclosureSEC source: 0001773751-25-000039 · wk-form4_1739308580.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,370 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. Read SEC document |
| February 04, 2025 Filed Feb 5, 2025 21:31 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 6,437 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001773751-25-000036 · wk-form4_1738791087.xml · derivative · entry 6 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 419,737 Underlying: Class A Common Stock · 6,437 shares Expires 2032-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F6 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date. Read SEC document |
| February 04, 2025 Filed Feb 5, 2025 21:31 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 997 | $39.30 | $39,186.89 |
DisclosureSEC source: 0001773751-25-000036 · wk-form4_1738791087.xml · nonDerivative · entry 5 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 112,933 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $39.25 - $39.43. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| February 04, 2025 Filed Feb 5, 2025 21:31 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 1,391 | $39.23 | $54,573.94 |
DisclosureSEC source: 0001773751-25-000036 · wk-form4_1738791087.xml · nonDerivative · entry 4 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 113,930 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $39.17 - $39.42. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| February 04, 2025 Filed Feb 5, 2025 21:31 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 1,913 | $39.20 | $74,992.28 |
DisclosureSEC source: 0001773751-25-000036 · wk-form4_1738791087.xml · nonDerivative · entry 3 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 115,321 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $39.00 - $39.42. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| February 04, 2025 Filed Feb 5, 2025 21:31 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 7,280 | $38.73 | $281,976.97 |
DisclosureSEC source: 0001773751-25-000036 · wk-form4_1738791087.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 117,234 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $38.40 - $38.96. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| February 04, 2025 Filed Feb 5, 2025 21:31 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 6,437 | $5.01 | $32,249.37 |
DisclosureSEC source: 0001773751-25-000036 · wk-form4_1738791087.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,514 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. Read SEC document |
| January 13, 2025 Filed Jan 14, 2025 21:31 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 6,437 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001773751-25-000010 · wk-form4_1736890295.xml · derivative · entry 5 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 426,174 Underlying: Class A Common Stock · 6,437 shares Expires 2032-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F5 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date. Read SEC document |
| January 13, 2025 Filed Jan 14, 2025 21:31 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 997 | $24.57 | $24,495.09 |
DisclosureSEC source: 0001773751-25-000010 · wk-form4_1736890295.xml · nonDerivative · entry 4 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,077 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $24.47 - $24.675. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 13, 2025 Filed Jan 14, 2025 21:31 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 1,391 | $24.54 | $34,140.15 |
DisclosureSEC source: 0001773751-25-000010 · wk-form4_1736890295.xml · nonDerivative · entry 3 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,074 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $24.46 - $24.69. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 13, 2025 Filed Jan 14, 2025 21:31 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 9,193 | $24.42 | $224,448.01 |
DisclosureSEC source: 0001773751-25-000010 · wk-form4_1736890295.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 120,465 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $24.21 - $24.63. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 13, 2025 Filed Jan 14, 2025 21:31 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 6,437 | $5.01 | $32,249.37 |
DisclosureSEC source: 0001773751-25-000010 · wk-form4_1736890295.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 129,658 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:40 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 6,437 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001773751-25-000004 · wk-form4_1736199598.xml · derivative · entry 5 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 432,611 Underlying: Class A Common Stock · 6,437 shares Expires 2032-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F5 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:40 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 997 | $24.66 | $24,589.21 |
DisclosureSEC source: 0001773751-25-000004 · wk-form4_1736199598.xml · nonDerivative · entry 4 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 123,221 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $24.63 - $24.81. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:40 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 1,391 | $24.71 | $34,373.70 |
DisclosureSEC source: 0001773751-25-000004 · wk-form4_1736199598.xml · nonDerivative · entry 3 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,218 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $24.61 - $24.83. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:40 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 9,193 | $24.67 | $226,820.73 |
DisclosureSEC source: 0001773751-25-000004 · wk-form4_1736199598.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 125,609 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $24.30 - $25.065. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:40 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 6,437 | $5.01 | $32,249.37 |
DisclosureSEC source: 0001773751-25-000004 · wk-form4_1736199598.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 134,802 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. Read SEC document |
| December 26, 2024 Filed Dec 27, 2024 21:48 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 4,213 | $29.98 | $126,317.96 |
DisclosureSEC source: 0001773751-24-000411 · wk-form4_1735336073.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 128,365 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.95 - $30.02. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 20, 2024 Filed Dec 23, 2024 21:40 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 4,213 | $25.75 | $108,489.38 |
DisclosureSEC source: 0001773751-24-000406 · wk-form4_1734990031.xml · nonDerivative · entry 4 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 132,578 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $25.64 - $25.92. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 20, 2024 Filed Dec 23, 2024 21:40 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 4,213 | $25.75 | $108,497.39 |
DisclosureSEC source: 0001773751-24-000406 · wk-form4_1734990031.xml · nonDerivative · entry 3 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 136,791 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $25.645 - $25.92. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 20, 2024 Filed Dec 23, 2024 21:40 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 6,320 | $25.80 | $163,047.15 |
DisclosureSEC source: 0001773751-24-000406 · wk-form4_1734990031.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,004 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $25.68 - $25.955. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 20, 2024 Filed Dec 23, 2024 21:40 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 4,213 | $25.75 | $108,496.97 |
DisclosureSEC source: 0001773751-24-000406 · wk-form4_1734990031.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 147,324 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $25.65 - $25.875. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 13, 2024 Filed Dec 18, 2024 00:02 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 22,988 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000396 · wk-form4_1734480121.xml · derivative · entry 5 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 298,845 Underlying: Class A Common Stock · 22,988 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. Read SEC document |
| December 13, 2024 Filed Dec 18, 2024 00:02 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 18,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000396 · wk-form4_1734480121.xml · derivative · entry 4 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,010 Underlying: Class A Common Stock · 18,334 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F4 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2023. F4 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2023. Read SEC document |
| December 13, 2024 Filed Dec 18, 2024 00:02 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 52,396 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000396 · wk-form4_1734480121.xml · derivative · entry 3 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 261,976 Underlying: Class A Common Stock · 52,396 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting 25% on March 15, 2023, and the remaining 75% vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting 25% on March 15, 2023, and the remaining 75% vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). Read SEC document |
| December 13, 2024 Filed Dec 18, 2024 00:02 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Tax withholdingClass A Common Stock | 51,573 | $30.02 | $1,548,221.46 |
DisclosureSEC source: 0001773751-24-000396 · wk-form4_1734480121.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,537 F2 · shares: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs. Read SEC document |
| December 13, 2024 Filed Dec 18, 2024 00:02 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 93,718 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-24-000396 · wk-form4_1734480121.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 203,110 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| November 25, 2024 Filed Nov 26, 2024 23:32 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 97,776 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001773751-24-000376 · wk-form4_1732663958.xml · derivative · entry 6 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 439,048 Underlying: Class A Common Stock · 97,776 shares Expires 2032-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F6 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date. Read SEC document |
| November 25, 2024 Filed Nov 26, 2024 23:32 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 90,412 | $30.01 | $2,713,010.97 |
DisclosureSEC source: 0001773751-24-000376 · wk-form4_1732663958.xml · nonDerivative · entry 5 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 109,392 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.95 - $30.13. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. F5 · balance_after: Includes 1,423 shares acquired on November 20, 2024, under the Hims & Hers Health, Inc. 2020 Employee Stock Purchase Plan. Read SEC document |
| November 25, 2024 Filed Nov 26, 2024 23:32 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 9,193 | $26.65 | $245,016.43 |
DisclosureSEC source: 0001773751-24-000376 · wk-form4_1732663958.xml · nonDerivative · entry 4 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 198,381 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $26.52 - $26.785. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| November 25, 2024 Filed Nov 26, 2024 23:32 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 997 | $26.58 | $26,498.57 |
DisclosureSEC source: 0001773751-24-000376 · wk-form4_1732663958.xml · nonDerivative · entry 3 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 207,574 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $26.52 - $26.62. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| November 25, 2024 Filed Nov 26, 2024 23:32 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 1,391 | $26.58 | $36,970.14 |
DisclosureSEC source: 0001773751-24-000376 · wk-form4_1732663958.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 208,571 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $26.52 - $26.62. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| November 25, 2024 Filed Nov 26, 2024 23:32 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 97,776 | $5.01 | $489,857.76 |
DisclosureSEC source: 0001773751-24-000376 · wk-form4_1732663958.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 209,962 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. Read SEC document |
| November 13, 2024 Filed Nov 14, 2024 21:57 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 83,209 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001773751-24-000357 · wk-form4_1731621448.xml · derivative · entry 8 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 536,824 Underlying: Class A Common Stock · 83,209 shares Expires 2032-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F7 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date. Read SEC document |
| November 13, 2024 Filed Nov 14, 2024 21:57 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 26,100 | $0.00 Strike: $11.53 | $0.00 |
DisclosureSEC source: 0001773751-24-000357 · wk-form4_1731621448.xml · derivative · entry 7 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,732 Underlying: Class A Common Stock · 26,100 shares Expires 2033-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F6 · derivative.exercise_date: The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023. Read SEC document |
| November 13, 2024 Filed Nov 14, 2024 21:57 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 131,305 | $30.06 | $3,947,067.69 |
DisclosureSEC source: 0001773751-24-000357 · wk-form4_1731621448.xml · nonDerivative · entry 6 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 112,186 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.95 - $30.42. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| November 13, 2024 Filed Nov 14, 2024 21:57 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 9,193 | $28.38 | $260,915.73 |
DisclosureSEC source: 0001773751-24-000357 · wk-form4_1731621448.xml · nonDerivative · entry 5 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 243,491 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $28.10 - $28.83. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| November 13, 2024 Filed Nov 14, 2024 21:57 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 1,391 | $28.72 | $39,954.11 |
DisclosureSEC source: 0001773751-24-000357 · wk-form4_1731621448.xml · nonDerivative · entry 4 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 252,684 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $28.16 - $28.815. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| November 13, 2024 Filed Nov 14, 2024 21:57 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 997 | $28.76 | $28,671.23 |
DisclosureSEC source: 0001773751-24-000357 · wk-form4_1731621448.xml · nonDerivative · entry 3 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 254,075 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $28.74 - $28.815. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| November 13, 2024 Filed Nov 14, 2024 21:57 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 83,209 | $5.01 | $416,877.09 |
DisclosureSEC source: 0001773751-24-000357 · wk-form4_1731621448.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 255,072 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. Read SEC document |
| November 13, 2024 Filed Nov 14, 2024 21:57 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 26,100 | $11.53 | $300,933.00 |
DisclosureSEC source: 0001773751-24-000357 · wk-form4_1731621448.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 171,863 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.